News
Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.
Latest Coverage
30 headlines
Tenable also intends to grant the initial purchasers of the notes an option to purchase, during a 13-day period beginning on, and including, the date on which the notes are first issued, up to an additional $65.0
BioLineRx Ltd. (NASDAQ:BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, and Hemispherian AS, a clinical-stage oncology company developing
Labcorp Holdings (NYSE:LH) affirms FY2026 Adj EPS guidance from $18.10-$18.55 to $18.10-$18.55 vs $18.01 analyst estimate. Affirms FY2026 sales outlook from $14.710 billion-$14.827 billion to $14.710 billion-$14.827
The collaboration is designed to remove two of the most persistent barriers facing emerging artists—securing high-quality visual content and earning meaningful exposure on mainstream radio. Through the partnership,
Filed: 2026-09-10 AccNo: 0001193125-26-387204 Size: 209 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Lovesac (NASDAQ:LOVE) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.36) by 2.78 percent. This is a 22.22 percent increase over losses of $(0.45) per share from the same
NEW YORK, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced an expansion of its relationship with Payward, the parent company of Kraken, including an agreement by Nasdaq Ventures to invest $100
Bitcoin may have bottomed, but mixed indicators remain. Holding above $80,000 could confirm recovery; rejection may trigger another decline.
Emerge Phase 3 study podium poster to be featured in "Latest Discoveries & Emerging Trends in MDD" sessionNew epidemiological research on risks associated with anxiety and depression plus five posters across
Filed: 2026-09-10 AccNo: 0001104659-26-106539 Size: 321 KB Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-10 AccNo: 0001084869-26-000024 Size: 2 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Backline is built using Xanadu’s open-source PennyLane software platform to solve one of quantum technology’s most pressing challenges: how to establish ultra-low-latency communication between classical processors and
RH reports quarterly earnings Sept. 10; analysts expect EPS to drop to 46 cents, while revenue rises to $916.5 million.
BMO Capital analyst Raj Ray downgrades Anglogold Ashanti (NYSE:AU) from Outperform to Market Perform and maintains the price target from $115 to $115.
Beamr has active Proofs of Concept (PoCs) with leading media companies for super resolution deployment. The Company will demonstrate Live and Archive AI enhancement at IBC 2026 in Amsterdam, September 11–14Herzliya,
Mental health represents a significant global healthcare opportunity, with more than 1 billion people globally1 living with a mental disorder and depression and anxiety alone estimated to cost the global economy
Filed: 2026-09-10 AccNo: 0001666700-26-000055 Size: 12 MB Item 1.01: Entry into a Material Definitive Agreement Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Analyst ratings highlight high-yield tech stocks Opera (4.52%), Amdocs (3.81%) and Accenture (3.71%), with mixed targets and recent in-line earnings.
Filed: 2026-09-10 AccNo: 0001104659-26-106538 Size: 5 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
VisionWave Holdings, Inc. (NASDAQ:VWAV) ("VisionWave" or the "Company"), an autonomous systems and sensing technology company, today announced the release of its September 2026 corporate overview,
Filed: 2026-09-10 AccNo: 0001493152-26-042072 Size: 233 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Filed: 2026-09-10 AccNo: 0001193125-26-387197 Size: 24 MB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
"Recent clinical data validated KAT6 as a targetable mechanism in the treatment of HR+/HER2- breast cancer, including those with actionable mutations," stated Charles Morris, MBChB, MRCP, Chief Medical Officer
Redwood Trust, Inc. (NYSE:RWT, "Redwood" or the "Company"))), a leader in expanding access to housing for homebuyers and renters, today announced that it plans to offer, subject to market and other
Baird analyst David Manthey maintains Core & Main (NYSE:CNM) with a Outperform and lowers the price target from $66 to $57.
Lovesac (NASDAQ:LOVE) is looking for Q3 GAAP EPS of $0.62-$0.83 vs $(0.53) analyst estimate. sees sales of $140.000 million-$150.000 million vs $159.835 million analyst estimate.
Transat A.T. (TSX:TRZ) reported quarterly losses of $(2.18) per share which missed the analyst consensus estimate of $(1.65) by 32.12 percent. This is a 678.57 percent decrease over losses of $(0.28) per share from the
Invenergy, North America’s largest privately held developer, owner and operator of independent power infrastructure, and HA Sustainable Infrastructure Capital, Inc. ("HASI") (NYSE:HASI), a leading investor in